Founded in 2021, Varda Space Industries operates in aerospace/space manufacturing. The latest valuation stands at $1B. Its shares do not trade on a public exchange.
2 valuations. The latest, $1B post-money, was set by the Series C/Later in Jan 2025.
Founders FundVvarious
Founders FundvariousVarda Space Industries designs, builds, and flies its own W-Series spacecraft, using microgravity to grow pharmaceutical crystals that are hard to produce under Earth's gravity, then returns them in a reentry capsule. Its W-1 capsule grew crystals of the antiretroviral drug ritonavir and became the first commercial spacecraft to land on a US military test range.
Will Bruey, a former SpaceX engineer, and Founders Fund partner Delian Asparouhov founded Varda in January 2021. It operates out of El Segundo, California and Washington, DC, and became a unicorn in 2025.
Listed funds carry late-stage private names. A fund's latest schedule of investments shows whether it holds Varda Space Industries.
Often trade at a premium or discount to NAV.
Platforms match existing holders with buyers. Varda Space Industries availability at any moment is set by the holders.
High minimums, transfer approval, company right-of-first-refusal.
Valuations, rounds and IPO status for every company in the directory — Varda Space Industries included.
No. Varda Space Industries is a private company; its shares do not trade on a public exchange.
The last valuation is $1B.
Lead investors for each round are in the funding timeline.
The closest aerospace/space manufacturing peers are on the competitors page.
The routes section explains what is realistically available for a company at this stage.